The USC IMSD program was initiated in April 2006. One successful strategy was to use IMSD funds to provide funding for UR students in the first year of a Ph.D. program in the biomedical sciences. Since the UR applicants were no longer competing with the non-UR and international applicants, we were able to take a chance on UR students who were not as well qualified on paper as most non-UR domestic applicants. As a result of this strategy, the number of UR students in USC Ph.D. programs in the biomedical sciences has increased by 140%. We expect this number to continue to increase since UR students have been 21% of the IBMSGP total admissions for the past two years. This year, UR students who have been supported by the USC IMSD program have begun to complete their doctoral degrees. The first to graduate has already published four research papers, has four more submitted, and is now a post- doctoral fellow at the Johns Hopkins University Medical School. During the next two years, we expect that six to eight additional UR students will complete their Ph.D. degrees. With continued funding, we anticipate that the number of UR students graduating from USC biomedical programs will reach at least seven per year, making a significant contribution the number of the UR students graduating with biomedical science doctorates in the United States.

Public Health Relevance

The USC IMSD program will increase the number of minority students who earn Ph.D. degrees in the biomedical sciences in the U. S. One consequence of this increase in minority scientists will be a more diverse biomedical research workforce that will be in a better position to provide the insights needed to address the problems of health disparities.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Education Projects (R25)
Project #
Application #
Study Section
Minority Programs Review Committee (MPRC)
Program Officer
Hagan, Ann A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of South Carolina at Columbia
Schools of Arts and Sciences
United States
Zip Code
Ely, Bert; Wilson, Kiesha; Ross, Keshawn et al. (2018) Genome Comparisons of Wild Isolates of Caulobacter crescentus Reveal Rates of Inversion and Horizontal Gene Transfer. Curr Microbiol :
Berrios, Louis; Ely, Bert (2018) Achieving Accurate Sequence and Annotation Data for Caulobacter vibrioides CB13. Curr Microbiol 75:1642-1648
Woappi, Yvon; Hosseinipour, Maria; Creek, Kim E et al. (2018) Stem Cell Properties of Normal Human Keratinocytes Determine Transformation Responses to Human Papillomavirus 16 DNA. J Virol 92:
Ash, Kurt T; Drake, Kristina M; Gibbs, Whitney S et al. (2017) Genomic Diversity of Type B3 Bacteriophages of Caulobacter crescentus. Curr Microbiol 74:779-786
Callahan, Courtney T; Wilson, Kiesha M; Ely, Bert (2016) Characterization of the Proteins Associated with Caulobacter crescentus Bacteriophage CbK Particles. Curr Microbiol 72:75-80
Scott, Derrick; Ely, Bert (2016) Conservation of the Essential Genome Among Caulobacter and Brevundimonas Species. Curr Microbiol 72:503-10
Velázquez, Kandy T; Enos, Reilly T; McClellan, Jamie L et al. (2016) MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer. Am J Physiol Gastrointest Liver Physiol 310:G347-58
Enos, Reilly T; Velázquez, Kandy T; McClellan, Jamie L et al. (2015) Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model. Nutr Res 35:449-59
Ely, Bert; Gibbs, Whitney; Diez, Simon et al. (2015) The Caulobacter crescentus transducing phage Cr30 is a unique member of the T4-like family of myophages. Curr Microbiol 70:854-8
Smith, Sherika N; Paige, Candler; Velazquez, Kandy T et al. (2015) Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents. J Pain 16:283-90

Showing the most recent 10 out of 57 publications